The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

A panel of CDC advisers, who had originally been set to meet in February, will discuss the current measles outbreak as well ...

The agency sets the immunisation schedules for adults and children in the US. At stake is an RSV vaccine market that has been estimated to be worth somewhere between $5 billion and $10 billion a ...

PRC vaccine leader AIM Vaccine (06660.HK) announced on February 26 that its self-developed mRNA RSV (Respiratory Syncytial Virus) vaccine has recently received clinical trial approval from the U.S ...

More Alberta seniors are now eligible for a provincially funded RSV vaccine. The provincial government announced in October it would provide the RSV shot, Abrysvo, for free to seniors 60 and up ...

The hospital has seen over 200 RSV admissions this winter, but a new preventative measure offers hope. "They came out with a vaccine for babies six months and younger, so that can definitely help ...

After the learning sessions, participants’ knowledge about RSV-related hospitalization risk increased from 40% to 65%. “The vaccination schedule for older adults, like for pediatric patients ...